FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:1621-1626 November 30, 2000 Number 22 Next

	Full Text PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Conflicts of interest pose a threat to the integrity of scientific research. The current regulations of the U.S. Public Health Service and the National Science Foundation require that medical schools and other research institutions report the existence of conflicts of interest to the funding agency but allow the institutions to manage conflicts internally. The regulations do not specify how to do so.

Methods We surveyed all medical schools (127) and other research institutions (170) that received more than $5 million in total grants annually from the National Institutes of Health or the National Science Foundation; 48 journals in basic science and clinical medicine; and 17 federal agencies in order to analyze their policies on conflicts of interest.

Results Of the 297 institutions, 250 (84 percent) responded by March 2000, as did 47 of the 48 journals and 16 of the 17 federal agencies. Fifteen of the 250 institutions (6 percent) — 5 medical schools and 10 other research institutions — reported that they had no policy on conflicts of interest. Among the institutions that had policies, there was marked variation in the definition and management of conflicts. Ninety-one percent had policies that adhered to the federal threshold for disclosure ($10,000 in annual income or equity in a relevant company or 5 percent ownership), and 9 percent had policies that exceeded the federal guidelines. Only 8 percent had policies requiring disclosure to funding agencies, only 7 percent had such policies regarding journals, and only 1 percent had policies requiring the disclosure of information to the relevant institutional review boards or to research subjects. Twenty journals (43 percent) reported that they had policies requiring disclosure of conflicts of interest. Only four federal agencies had policies that explicitly addressed conflicts of interest in extramural research, and all but one of the agencies relied primarily on institutional discretion.

Conclusions There is substantial variation among policies on conflicts of interest at medical schools and other research institutions. This variation, combined with the fact that many scientific journals and funding agencies do not require disclosure of conflicts of interest, suggests that the current standards may not be adequate to maintain a high level of scientific integrity.

Source Information

From the Center for Medical Ethics and Health Policy (S.V.M., J.J., T.K., L.B.M., N.P.W., B.A.B.) and the Department of Medicine (S.V.M., C.B.A., L.B.M., N.P.W., B.A.B.), Baylor College of Medicine; and the Houston Center for Quality of Care and Utilization Studies, Veterans Affairs Medical Center (C.B.A., N.P.W.) — both in Houston.

Address reprint requests to Dr. McCrary at the Center for Medical Ethics and Health Policy, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030-3498.

Full Text of this Article

This article has been cited by other articles:

• Claxton, L. (2007). A review of conflict of interest, competing interest, and bias for toxicologists.. Toxicol Ind Health 23: 557-571 [Abstract]  
• Reed, D. A., Cook, D. A., Beckman, T. J., Levine, R. B., Kern, D. E., Wright, S. M. (2007). Association Between Funding and Quality of Published Medical Education Research. JAMA 298: 1002-1009 [Abstract] [Full Text]  
• Parascandola, M. (2007). A Turning Point for Conflicts of Interest: The Controversy Over the National Academy of Sciences' First Conflicts of Interest Disclosure Policy. JCO 25: 3774-3779 [Abstract] [Full Text]  
• Gray, S. W., Hlubocky, F. J., Ratain, M. J., Daugherty, C. K. (2007). Attitudes Toward Research Participation and Investigator Conflicts of Interest Among Advanced Cancer Patients Participating in Early Phase Clinical Trials. JCO 25: 3488-3494 [Abstract] [Full Text]  
• Jacobs, J. J., Galante, J. O., Mirza, S. K., Zdeblick, T. (2006). Symposium. Relationships with Industry: Critical for New Technology or an Unnecessary Evil?. JBJS 88: 1650-1663 [Full Text]  
• Lexchin, J., Light, D. W (2006). Commercial influence and the content of medical journals.. BMJ 332: 1444-1447 [Full Text]  
• Sharp, R. R., Yarborough, M. (2006). Informed Trust and the Financing of Biomedical Research. J Law Med Ethics 34: 460-464  
• Brody, B. A., McCullough, L. B., Sharp, R. R. (2005). Consensus and Controversy in Clinical Research Ethics. JAMA 294: 1411-1414 [Full Text]  
• Stossel, T. P. (2005). Regulating Academic-Industrial Research Relationships -- Solving Problems or Stifling Progress?. NEJM 353: 1060-1065 [Full Text]  
• Emanuel, E. J., Wood, A., Fleischman, A., Bowen, A., Getz, K. A., Grady, C., Levine, C., Hammerschmidt, D. E., Faden, R., Eckenwiler, L., Muse, C. T., Sugarman, J. (2004). Oversight of Human Participants Research: Identifying Problems To Evaluate Reform Proposals. ANN INTERN MED 141: 282-291 [Abstract] [Full Text]  
• Helft, P. R., Ratain, M. J., Epstein, R. A., Siegler, M. (2004). Inside Information: Financial Conflicts of Interest for Research Subjects in Early Phase Clinical Trials. JNCI J Natl Cancer Inst 96: 656-661 [Abstract] [Full Text]  
• Kim, S Y H, Millard, R W, Nisbet, P, Cox, C, Caine, E D (2004). Potential research participants' views regarding researcher and institutional financial conflicts of interest. J. Med. Ethics 30: 73-79 [Abstract] [Full Text]  
• Bruce Fye, W. (2003). The power of clinical trials and guidelines,and the challenge of conflicts of interest. J Am Coll Cardiol 41: 1237-1242 [Full Text]  
• Bekelman, J. E., Li, Y., Gross, C. P. (2003). Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review. JAMA 289: 454-465 [Abstract] [Full Text]  
• Sollitto, S., Youngner, S., Lederman, M. M. (2002). Nonfinancial Conflicts of Interest in Research. NEJM 347: 2173-2173 [Full Text]  
• Schulman, K. A., Seils, D. M., Timbie, J. W., Sugarman, J., Dame, L. A., Weinfurt, K. P., Mark, D. B., Califf, R. M. (2002). A National Survey of Provisions in Clinical-Trial Agreements between Medical Schools and Industry Sponsors. NEJM 347: 1335-1341 [Abstract] [Full Text]  
• Miller, F. G., Shorr, A. F. (2002). Ethical Assessment of Industry-Sponsored Clinical Trials* : A Case Analysis. Chest 121: 1337-1342 [Abstract] [Full Text]  
• Kalb, P. E., Koehler, K. G. (2002). Legal Issues in Scientific Research. JAMA 287: 85-91 [Abstract] [Full Text]  
• Lewis, S., Baird, P., Evans, R. G., Ghali, W. A., Wright, C. J., Gibson, E., Baylis, F. (2001). Dancing with the porcupine: rules for governing the university-industry relationship. CMAJ 165: 783-785 [Full Text]  
• DeAngelis, C. D., Fontanarosa, P. B., Flanagin, A. (2001). Reporting Financial Conflicts of Interest and Relationships Between Investigators and Research Sponsors. JAMA 286: 89-91 [Full Text]  
• Parmley, W. W. (2001). Changing guidelines on conflict of interest. J Am Coll Cardiol 37: 1749-1750 [Full Text]  
• Topol, E. J., Nurok, M., Ratain, M. J., Sheridan, M. E., Lo, B., Wolf, L., McCrary, S. V., McCullough, L. B., Brody, B. A., Martin, J. B., Kasper, D. L. (2001). Conflict-of-Interest Policies. NEJM 344: 1017-1018 [Full Text]  
• Sheppard, R., Eisenberg, M. J. (2001). Intracoronary Radiotherapy for Restenosis. NEJM 344: 295-297 [Full Text]  
• Drazen, J. M., Koski, G. (2000). To Protect Those Who Serve. NEJM 343: 1643-1645 [Full Text]  
• Martin, J. B., Kasper, D. L. (2000). In Whose Best Interest? Breaching the Academic-Industrial Wall. NEJM 343: 1646-1649 [Full Text]